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1. Introduction 
It appears that for some time diastole was taken for granted and largely ignored. Systole 
was thought of as the only function that truly predicted cardiac risk. The fact that diastolic 
heart failure (DHF) was referred to at one point as “heart failure with normal ejection 
fraction (EF)” lends credence to this assumption. It has been proven since that cardiac 
relaxation is an active energy-dependent process that begins in late systole and extends into 
early or mid-diastole (Shah & Pai, 1992). The fact that diastolic dysfunction contributes to up 
to half of the cases of heart failure dispelled the myth that systolic function is the only factor 
to consider in cardiac risk assessments (Bhatia etal., 2006, Owan etal., 2006, Vasan etal., 
1995). Cardiologists are ahead of surgeons in recognizing the importance of diastolic 
function in clinical practice. They have noticed that changes in diastolic filling pattern are of 
a prognostic value following myocardial infarction. Left ventricular remodeling following 
acute myocardial infarction (AMI) is a well known phenomenon occurring in the earliest 
post infarction phase and continuing for weeks or months. A restrictive transmitral filling 
pattern which is a marker of diastolic dysfunction provides significant information in these 
patients. A short initial deceleration time (DT) < 150 ms obtained as early as 1 day after AMI 
can identify patients who are likely to undergo LV remodeling in the following year 
(Otasević ,2001). Remodeling is a precursor of heart failure and a strong predictor of 
mortality. Therefore, an early restrictive filling pattern as evidenced by a short DT identifies 
patients who are likely to develop progressive LV dilation and dysfunction. Persistence of a 
restrictive filling pattern is the most powerful independent predictor of severe dilation and 
late mortality (Temporelli etal, ,2004, Whalley etal, 2006), The importance of diastolic 
dysfunction to the surgeon became apparent when it was established that it is a predictor of 
difficult weaning off cardiopulmonary bypass and mortality (Bernard etal, 2001, Salem etal, 
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2006). Finally, the impact of diastolic dysfunction affects the anesthesiologist as these 
patients may tolerate acute preload reduction with induction of anesthesia poorly leading to 
low cardiac output and hypotension. This patient population presents difficult anesthetic 
challenges and places these patients at high risk of perioperative morbidity and mortality 
(Couture etal, 2009 Sanders etal, 2009). In short, diastolic dysfunction has touched every 
facet of clinical practice. This chapter will predominantly focus on DHF (with normal EF) as 
distinct to the combined systolic and diastolic failure. 
2. Clinical spectrum 
Diastolic dysfunction can be defined as the inability of the left ventricle to adequately fill at 
low or normal atrial pressures unrelated to intrinsic valve disease or pericardial pathology. 
This dysfunction can result either from an impairment in LV compliance (passive 
mechanism) or from an alteration in LV relaxation (active process).  
Since not all patients who undergo heart surgery have a normal EF, the classical definition 
of DHF of heart failure with normal EF does not always apply. It is therefore necessary not 
to overlook the status of the preoperative EF when assessing the DHF in the postoperative 
heart. With this understanding DHF in the postoperative state is better defined as a clinical 
syndrome of heart failure with a preserved left ventricular EF in the absence of major valve 
disease or pericardial pathology (Vasan & Levy, 2000 Vasan, 2003). It is associated with 
abnormalities of diastolic distensibility, filling, or relaxation of the left ventricle (Gaasch & 
Zile, 2004) clinically; DHF is usually accompanied by severe reduction of exercise capacity, 
neuroendocrine activation, and poor quality of life. Typically the ventricle has thick walls 
and a small cavity (increased left ventricular mass/volume ratio) (Kitzman etal, 2000). In 
contrast to systolic heart failure, DHF affects women more frequently. DHF can occur alone 
or in combination with systolic heart failure. In isolated DHF (characterized as a small stiff 
heart), the only abnormality in the pressure-volume relationship occurs during diastole, 
when there are increased diastolic pressures with a low end diastolic volume. In systolic heart 
failure, the abnormalities in the pressure-volume relationship during systole include decreased 
EF, stroke volume and stroke work. If there are in addition, changes in the diastolic portion of 
the pressure-volume relationship that leads to increased diastolic pressures, the implication 
then is that there is both systolic and diastolic cardiac failure (Zile &, Brutsaert , 2002; Deswal, 
2005; Burkhoff etal. 2003).These concepts are depicted in Figure 1, using simplified pressure-
volume loops, and showing the left ventricular end-diastolic pressure-volume curves. The 
normal left ventricle is shown with (LVEDP) < 16 mmHg. For DHF, the loop is smaller 
indicating reduced stroke volume, and shifted up and to the left, with LVEDP > 16 mmHg. It 
is important to note, that the end-diastolic volume in DHF is at the lower range of normal. In 
contrast, the end-diastolic volume in patients with systolic failure is increased.  
3. Mechanics of diastole 
Ventricular relaxation is an active energy-dependent process that begins in late systole and 
extends into early or mid-diastole (van Kraaij et al.2003). Relaxation can be defined as the 
time period during which the myocardium loses its ability to generate force and further 
shortening, and returns to an unstressed length and force (Zile &, Brutsaert, 2002) Diastole 
begins at the closure of the aortic valve and lasts until closure of the mitral valve 
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Fig. 1. Pressure–volume loop diagram indicating the position of the end-diastolic pressure–
volume on curve for DHF; normal diastolic function (Normal); systolic failure (SF), and 
systolic and diastolic failure (S+DHF). A horizontal dashed line at >16 mmHg indicates 
division between normal and raised end-diastolic pressure. Adapted with permission from 
Elsevier Publishing (Alsaddique etal 2009] 
(Kawaguchi et al, 2003). Broadly speaking, diastole can be looked at as two phases; 
isovolumetric relaxation corresponds to LV pressure decline at constant volume, that lasts 
from the closure of the aortic valve to opening of the mitral valve. The second phase is 
auxotonic relaxation corresponding to LV filling lasting until closure of the mitral valve. LV 
filling depends mainly on the pressure gradient between the LA and LV which is influenced 
by ventricular compliance, active relaxation, and augmented by atrial contraction towards 
end-diastole. Traditionally however, diastole is divided into four distinct phases: 
isovolumetric relaxation, early rapid ventricular filling, diastasis and atrial systole. The 
isovolumic relaxation time is a continuum of systole and is dependent on it. The early rapid 
ventricular filling phase is dependent on LV relaxation and compliance. Diastasis is 
dependent on both the heart rate and chamber compliance. The atrial contraction depends 
on the chamber compliance, left atrial (LA) function and the conduction system of the heart. 
At the cellular level, diastole begins when adenosine triphosphate hydrolyzes and actin-
myosin cross bridges unlink, leading to sarcomeric relaxation. This is related to decreases in 
cytoplasmic Ca2 + and the subsequent dissociation of Ca2 + from troponin C. The majority of 
cytosolic Ca2 + is actively resequestered into the sarcoplasmic reticulum via the sarcoplasmic 
reticulum Ca2 +ATPase (SERCA2). The remaining cytosolic calcium is removed by the 
sarcolemmal sodium calcium exchanger and other mechanisms (Groban, 2005). Diastolic 
function depends on the passive elastic recoil properties of the LV as well as active 
relaxation. Impaired active myocardial relaxation causes a slow decline in the left 
ventricular intracavity pressure. The mitral valve opens later, as left atrial filling needs to 
increase in order to provide a positive gradient across the mitral valve. In severe cases, an 
increased left atrial pressure state is developed so as to exceed the (increased) left 
ventricular intracavity pressure (Aurigemma & Gaasch , 2004). An increase in passive 
chamber compliance can also produce the same pattern and result in elevated LVEDP, 
thereby necessitating an increased left atrial pressure to provide a driving gradient (Zile et 
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al, 2004). The mechanisms that cause diastolic dysfunction are multifactorial (Kiss etal, 
2004). However, they can be broadly categorized as intrinsic (that is affecting the ventricular 
muscle) or extrinsic (any process that can cause external compression of the left ventricle). A 
summary of these causes is shown in Table 1. Whilst many of these causes are not reversible 
in the short term, it is important for clinicians to understand potentially reversible causes so 
that they can be readily identified and treated. An example of extrinsic pathology is a 
distended abdomen caused by dilated stomach and bowels actively pushing on the 
diaphragm, compressing the heart and interfering with cardiac filling, thereby leading to or 
exacerbating the development of DHF. The major factors that affect diastolic function are 
ventricular relaxation and compliance. Other factors that influence diastolic function to a 
lesser degree include systolic function, left atrial pressure, the pericardium, and 
intrathoracic pressure (Wu &Yu , 2005). In diastolic dysfunction relaxation abnormalities 
appear early and the inability of the left ventricle to fill in early diastole significantly affect 
the rapid filling phase resulting in a compensatory increase in filling with atrial contraction. 
The other factor that determines LV filling is chamber compliance (distensibility of the 
ventricles), defined as the change in volume over the change in pressure (dV/dP). It can be 
derived using the relationship between changes in end diastolic pressure (EDP) and end 
diastolic volume (EDV) by using the formula:  
Compliance = Δ EDV / Δ EDP (Gilbert &,Glantz, 1989; Lewis &, Gotsman, 1976) 
When ventricular compliance begins to decrease the EDP rises, but the EDV remains 
unchanged. The increase in EDP reduces the pressure gradient across the mitral valve 
leading to reduced ventricular filling culminating in decreased cardiac output. Diastolic 
relaxation is more sensitive to ischemia than systolic contraction, and may lead to subtle 
relaxation abnormalities without systolic impairment (Garcia-Fernandez etal, 1999). In 
coronary artery disease, ventricular relaxation as reflected in the early diastolic filling rate 
may be impaired at rest. 
4. Contributing factors 
Primary diastolic failure is typically seen in patients with hypertensive or valvular heart 
disease as well as in hypertrophic or restrictive cardiomyopathy but can also occur in a variety 
of other clinical situations. The main risk factors for this form of heart failure are advancing 
age, hypertension, and diabetes mellitus (- Zile & Gaasch 2001). There is a high incidence of 
diastolic dysfunction among normotensive patients with diabetes mellitus (Boyer etal, 2004). 
Increased matrix collagen, interstitial fibrosis, myocardial microangiopathy, and myocytes 
hypertrophy are common findings in the diabetic heart that can lead to diastolic dysfunction. 
Tight glycemic control decreases the risk of heart failure in patients with diabetes (Iribarren 
etal, 2001; Liu etal, 2001).The defect in DHF is a combination of impaired ventricular relaxation 
and a decrease in passive ventricular distensibility (Aurigemma & Gaasch, 2004; Zile etal, 
2004). The low cardiac output associated with DHF is due to inadequate ventricular filling, not 
impaired systolic contraction, and is an important point to remember when managing these 
patients. LV filling depends mainly on the pressure gradient between the LA and LV which is 
influenced by compliance, active relaxation, and at end diastole by atrial contraction (Appleton 
etal, 2000). There are number of predisposing factors that can contribute to DHF in the 
postoperative cardiac surgical patient. The mechanisms by which these factors exert their 
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Intrinsic causes 
Cause Comment 
Delay in active relaxation Any cause that interferes with myofilament cross-bridge 
detachment. Includes poor calcium sequestration, 
abnormal calcium sensitivity, myocardial ischemia, 
abnormal sodium/calcium exchanger or alteration in the 
myocyte calcium-handling proteins 
Abnormal “cardiac spring” During contraction, molecular springs such as Titan 
molecules are compressed, and during diastole contribute 
to chamber expansion via mechanical elastic recoil. 
Abnormalities of these molecules may cause diastolic 
heart failure. It also underlines the importance of systolic 
function in early diastolic recoil. 
Myocardial fibrosis Abnormalities of collagen, or other infiltrative processes 
(such as amyloid), may increase ventricular wall stiffness 
by a variety of mechanisms 
Left ventricular hypertrophy This is associated but not necessarily causative of diastolic 
dysfunction. Chronic increased load such as hypertension 
or aortic stenosis may also cause changes in collagen 
composition. 
Acute myocardial ischemia Active relaxation is highly energy dependent, and acute 
myocardial ischemia will lead to (reversible) diastolic 
dysfunction 
Extrinsic causes 
Right ventricle pressure or 
volume overload 
The right ventricle physically compresses the left ventricle. 
In severe cases, the left ventricle becomes D-shaped rather 
than O-shaped. Any course of pressure or volume 
overload, including pulmonary hypertension will 
exacerbate left-sided diastolic dysfunction. 
 Pericardium  Pericardial fluid or restrictive pericardial disease will 
limit ventricular filling or physically compress the left 
ventricle. 
Pleural fluid A large pleural effusion may compress the heart 
Hyper inflated lungs Pressure from the lungs is transmitted via the pericardium 
to the heart. Severe lung hyperinflation mimics pericardial 
tamponade. High levels of PEEP are similar. 
Distended abdomen Fluid, fat, or gaseous distension can cause myocardial 
compression, particularly in the supine patient 
Table 1. Causes of diastolic dysfunction 
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effect are briefly explained. Atrial fibrillation is a common occurrence in the postoperative 
period. It causes loss of atrial contraction that results in impaired diastolic filling. Myocardial 
hypertrophy is another predisposing factor found in some of the valvular lesions and in 
hypertensive patients. Its presence interferes with the passive late phase of diastolic filling of 
the LV contributing to diastolic dysfunction. Myocardial ischemia in the postoperative 
cardiac surgical patient significantly slows active myocardial relaxation during early 
diastole. It may also lead to rhythm disturbances that will further aggravate LV diastolic 
dysfunction. Tachyarrhythmias impair LV filling by shortening the diastolic phase of the 
cardiac cycle resulting in impaired LV filling (- Zile & Brutsaert, 2002). The effect of positive 
pressure ventilation (to which virtually all of open heart surgery patients are subjected to 
postoperatively) on cardiac performance is complex involving changes in preload and 
afterload for both right and left ventricles. Positive pressure ventilation can lower 
ventricular filling, and may also reduce afterload, enhancing ventricular emptying during 
systole. The effect on cardiac output depends on whether the effect on preload or afterload 
predominates. If the patient is normovolemic and intrathoracic pressure are within normal 
the effect on afterload reduction predominates resulting in an increase in the cardiac output. 
The increase in stroke volume leads to increase in systolic blood pressure during lung 
inflation results in a phenomenon known as reverse pulsus paradoxus. The beneficial effects 
of positive pressure ventilation on cardiac output are reversed by hypovolemia leading to 
decreased cardiac output and hypotension (Pinsky , 2005 2007)]. Pericardial constriction or 
tamponade causes increased resistance to diastolic filling and physiologically is “acute 
severe extrinsic diastolic failure” whereby the heart becomes physically compressed by the 
pericardial effusion. Renal insufficiency results in volume overload that leads to a slowing 
of myocardial relaxation potentially contributing to DHF (Tsuyuk etal, 2001). Chronic 
anemia is usually accompanied by an increase in cardiac mass due to volume overload. In 
the animal model, chronic anemia resulted in increased left ventricular end-diastolic 
pressure and decreased functional reserve which in turn can lead to diastolic dysfunction. It 
can also lead to tachycardia that it turn shortens diastole resulting in diastolic dysfunction. 
The anemia that is seen in the postoperative period due to excessive postoperative blood 
loss is transient, acute and is often rapidly corrected in these patients leading to very little if 
any effect on the diastolic function (Rakusan, etal 2001). Chronically uncontrolled 
hypertension is by far the most common predisposing factor in for DHF. It can lead to DHF 
through a number of ways; one of them is by causing LV hypertrophy that can results in a 
delayed LV relaxation with all its attendant effects on diastolic filling. The other mechanism 
is related to a reduced arterial compliance that can also contribute to diastolic dysfunction 
(Mottram etal, 2005). Hypertension that is seen at times in the postoperative period is 
usually transient is quickly managed and therefore does not pose the same risk of the more 
common form of hypertension. At times one may need to pace the heart in the post 
operative period; as most pacing wires placed at surgery are ventricular, pacing under these 
circumstances would affect diastolic filling bringing about diastolic dysfunction or could 
even trigger DHF in some instances. This is largely due to the loss of the atrial contribution 
to LV filling (Alsaddique, 2008). It is therefore better to keep this possibility in mind and 
make the extra effort of placing both atrial and ventricular wires for sequential pacing. 
There seems to be some evidence that Nitric Oxide (NO) metabolism plays a role in acute 
diastolic dysfunction following episodes of ischemia and reperfusion. It is thought that NO 
could have a beneficial role as pretreatment with cyclic guanosine monophosphate (cGMP) 
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donors, or with NO donors protects myocytes from relaxation failure in animal models 
(Schlüter etal, 1994; Draper & Shah, 1997; du Toit etal, 1998).  
5. Assessment of diastolic function 
5.1 Echocardiography evaluation 
Transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE) play a 
major role in the assessment of diastolic function. A combination of 2-dimensional 
echocardiography, pulsed wave Doppler, Color M-mode (CMM) and Tissue Doppler 
imaging (TDI) are used in combination to categorize the grade of diastolic dysfunciton.  
2-D echocardiography is used to assess ventricular dimensions, LV mass, EF and LA size. 
Pulsed wave Poppler (PWD) measures the velocity of blood at the cursor position. The mitral 
inflow Doppler spectral display is composed of an E (early) wave for passive diastolic filling 
followed by an A (atrial) wave for atrial systole. Mitral blood flow is affected by LV relaxation, 
LV compliance, and the LA-LV pressure gradient. PWD is used to assess transmitral flow 
velocity recording and pulmonary vein flow velocity variables in the evaluation of diastolic 
dysfunction (Hunt etal, 2001; Vasan & Levy, 2000). The four useful variables from mitral flow 
are: peak early diastolic transmitral flow velocity (E), peak late diastolic transmitral flow 
velocity (A), early filling deceleration time (DT) and A wave duration [Adur] (Myśliński etal, 
2002; Appleton etal, 1988). A normal E/A ratio is considered to be between 0.75 and 1.5. Early 
filling DT reflects LV compliance in early diastole. The normal DT is usually less than 200 
milliseconds in young patients and may exceed 200 ms in patients over 60 years of age (Garcia 
etal, 1998). Pulmonary venous (PV) flow is composed of systolic and diastolic waves, and an 
atrial contraction reversal wave. The normal patterns is systolic predominance, but this is 
reversed when the LAP is elevated. In high LAP, the atrial reversal wave increased in duration 
such that it exceeds the mitral A wave duration. The major problem with the use of PV flow 
variables is the difficulty in obtaining adequate measurement when using TTE. The Doppler 
flow parameters are influenced by a variety of factors including altered loading conditions and 
heart rate, and not all patients “fit the pattern” (Appleton etal, 2001; Pirracchio etal, 2007). In the 
operative and critical care settings, the loading conditions and heart rates change frequently, 
and the patterns may alter without significant change in chamber compliance. Therefore, the 
results from these measurements may be inconsistent and accordingly inconclusive in the 
postoperative cardiac surgical patient. Color M-mode (CMM) Doppler flow propagation 
velocity (Vp) is an easily obtained diastolic index. It displays velocity information a long a line 
that extends from the mitral valve to the LV apex, providing superior temporal resolution (5 
milliseconds), spatial resolution (1mm) and velocity resolution (5 cm/s). The commonly used 
variable for CMM Doppler is the Vp into the LV which is the velocity at which the blood 
travels from the mitral valve to the LV apex. In sinus rhythm CMM is characterized by 2 
distinct waves, one corresponds to the E wave and the second one to the A wave. 
Vp relates well to LV relaxation and is claimed to be relatively load independent. A Vp 
value of less than 45 cm / s is consistent with diastolic dysfunction in patients older than 30 
years of age < 55 cm/s in patients less than 30 years of age (Onose etal, 1999; Dumesnil, etal, 
1991). However, a major limitation of Vp is that it is heart rate dependent and in the 
perioperative setting, heart rate changes frequently.  
Tissue Doppler imaging (TDI) is an ultrasound imaging modality that directly measures 
myocardial velocity during the cardiac cycle and allows wall movement to be directly 
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analyzed (Vitarelli &, Gheorghiade, 1998; Dokainish, 2004). The myocardial portion 
commonly studied is above the mitral annulus at either the septal or lateral walls. Three 
wave forms are described, Peak systolic wave, early diastolic wave (Ea) and the end 
diastolic wave (aʹ) related to the atrial contraction. The Ea wave is relatively independent of 
loading state and is used to assess LV relaxation, a cut off of 8 cm /s for septal Ea or < 10 
cm/s for lateral wall Ea measurement is now widely accepted as a sign of diastolic 
dysfunction (Sohn etal, 1997). It is easy to perform and available in the majority of patients 
even if the 2-D imaging is poor, and holds promise as a method to quantify change in 
diastolic function. When measuring TDI, Khouri and associates measure only early diastolic 
myocardial velocity (eʹ) at the lateral corner of the mitral annulus, because it has been noted 
that the lateral annular velocity is more reproducible than the septal annular velocity 
(Khouri etal, 2004). Figure 2 reveals Echocardiographic findings typical of DHF pattern. 
Transthoracic echocardiography (TTE) is not always possible in the postoperative situation, 
due to hemodynamic instability, mediastinal air, the close proximity to a fresh surgical 
wound, presence of drains and dressings, or due to the inability to position the patient in an 
optimum way. In addition, mechanical ventilation with high positive end-expiratory 
pressure, pacing wires, ECG leads further add to the obstacles for the desired examination 
window resulting in a poor image quality.  
LV normal size
Normal EF (70%)
Lateral wall
E’ <1- cm/s
Pulmonary vein
S<D
Pseudonormal
MV Doppler
 
Fig. 2 Typical diastolic failure (small stiff heart) typically Grade 2 American Society of 
Echocardiography (ASE). 
This is a common pattern in the periopertive setting. Typically Cardiac Index (CI ) 1.8-2.2 
l/min/m2 Pulmonary Artery Wedge Pressur( PCWP) > 15 mmHg  
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5.2 Use of Transesophageal Echocardiography (TEE) 
TEE has a well established role in cardiac surgery as it has proved to be a valuable tool for 
intraoperative decisions particularly in valve surgery (Eltzschig etal, 2008). In addition, it 
has also proved to be useful in the field of intensive care for the assessment of 
hemodynamics and to track its variations after therapeutic interventions. Repeated 
measurements of left ventricular end-diastolic dimension are recommended in order to 
accurately track the hemodynamic changes, as a single determination is not felt to be 
reliable. TEE can adequately assess right ventricular function and left ventricular filling 
pressure using combined Doppler modalities (Vignon, 2005). The same parameters that are 
described for assessing diastolic function utilizing TTE can be achieved using TEE (Groban& 
Dolinski , 2005; Klein etal, 1999) though caution should be exercised as many of the Doppler 
parameters have not been extensively validated in sedated and ventilated patients.  
5.3 Identifying a high left atrial pressure 
A simple way to conceptualize diastolic failure is to recognize that if high left atrial pressure 
is present, then clinically important diastolic failure is present, as the body has had to adapt 
to a stiff ventricle by raising the LAP sufficient to provide an adequate transmitral driving 
gradient to fill the LV. Figure 3 High LAP can be diagnosed by invasive monitoring (such as 
a pulmonary artery catheter), or non-invasively with TTE or TEE. A simple pattern that can 
be easily recognized is that of a tense left atrium, evident by a fixed curve of the interatrial 
septum pointing from the left to the right atria. When the LAP is normal, the interatrial 
septum changes direction to point to the left atrium during mid-systole. Once a high LAP is 
detected, then echocardiography is focused on the chamber dimensions and EF to determine 
if it is DHF (small LV with normal EF), or systolic and diastolic failure (large heart with 
reduced EF).  
Categorizing Diastolic Dysfunction
Clinically Unimportant Clinically Important
Normal LAP Raised LAP
Normal size or may be dilated 
LV
EF normal or may be reduced
Hemodynamic state
- normal or 
- systolic failure
Small  heart Dilated heart
EF “low normal” to normal EF reduced
Hemodynamic state
- Primary diastolic failure
Hemodynamic state
-Systolic and
diastolic failure
 
Fig. 3. Flow chart to categorize diastolic dysfunction. Clinically important diastolic failure is 
associated with raised left atrial pressure. Diastolic dysfunction with normal left atrial 
pressure does not usually affect hemodynamic stability.The key is to identify high LAP and 
then identify if the LV volume is small to normal or dilated, in order to differentiate primary 
diastolic failure form systolic and diastolic failure.  
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5.4 Natriuretic peptides 
B-type Natriuretic peptide (BNP) is a marker of systolic left ventricular dysfunction and 
heart failure. It however increases in subjects with diastolic dysfunction (mean 20.3+/-4.7 
pg/ml vs. control 9.6+/-0.5 pg/ml, p<0.001). A normal BNP level virtually excluded the 
presence of diastolic dysfunction and concomitant left ventricular hypertrophy (LVH). 
Increased BNP concentrations in subjects with diastolic dysfunction are strongly related to 
LVH (Lukowicz etal, 2005).] In patients with normal systolic function, elevated BNP levels 
and diastolic filling abnormalities might help to reinforce the diagnosis diastolic dysfunction 
(Lubien etal, 2002; Krishnaswamy etal, 2001) A-type atrial, natriuretic peptide (ANP) is 
secreted from the atria in response to dilatation. Brain-type (B-type) natriuretic peptide 
(BNP) is a neurohormone that is released by the cardiac myocytes when left ventricular wall 
stress increases. After secretion the pro-hormone is cleaved to the biologically active 
hormone (BNP) and an inactive N-terminal fragment (N-BNP) Plasma levels of BNP 
increase in direct relation to increase in ventricular end-diastolic volume and end-diastolic 
pressure of both right and left side(Stewart, 2005). A rise in BNP produces vasodilatation 
and increase in renal sodium excretion (Maisel etal, 2002). Atrial natriuretic peptide and 
brain natriuretic peptide are known to be indices for heart failure. Postoperative ANP 
plateaus on the third postoperative day and decreases gradually down to the preoperative 
level by one month Postoperative BNP plateaus, showing very slow decrease and it never 
returning to the preoperative level (Song etal, 2004; Bail etal, 2004)]. This pattern of changes 
in the BNP and ANP levels after cardiac surgery makes it rather impractical to use them as 
markers for heart failure in the immediate postoperative setting of these patients. 
5.5 Cardiac catheterization 
The characteristic finding of DHF is an elevated left ventricular end diastolic pressure 
(LVEDP) over 16 mm Hg in the presence of a normal LV chamber size (van Heerebeek etal 
2006; Kitzman etal, 2002) Vasan and Levy recommended cardiac catheterization as a 
prerequisite for making the diagnosis of a definite DHF (Vasan & Levy 2000). In the post-
operative setting of a fresh open heart surgery cardiac, catheterization is probably not 
warranted and the diagnosis can be made by less invasive means. 
5.6 Multidetector CT (MDCT) of the heart 
Cardiac MDCT is most commonly performed for the purpose of noninvasive cardiac 
angiography. Image data are acquired continuously during a single breath-hold scan, 
typically 10 to 15 seconds in duration. Contrast is required for angiography and for 
endocardial border definition, with typical doses in the range of 60 to 80 mL per scan, quite 
comparable to a diagnostic cardiac catheterization. Patients with cardiomyopathies of all 
etiologies represent a large and growing population that stands to benefit from advanced 
imaging techniques (Sibley & Lima, 2008). Electron-beam computed tomography (EBCT) 
has been shown to be a reliable tool for the assessment of ventricular diastolic function and 
to detect constrictive filling pattern (Kloeters etal, 2008; Rumberger, 2000). These tools 
cannot be utilized in the assessment of the post operative heart for logistical reasons  
5.7 Cardiac magnetic resonance 
Cardiac magnetic resonance (CMR) is the latest addition to the diagnostic tools. The specific 
advantage of cardiac magnetic resonance (CMR) over echocardiography is the possibility to 
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acquire images in any selected plane or along any selected axis. A routine CMR examination 
in the setting of heart failure will acquire short access images covering the entire heart from 
base to apex in addition, to the long access slices. It can also provide a range of LV filling 
parameters almost similar to those obtained by echocardiography (Rademakers & Bogaert , 
2006; Hauser etal, 2004) . CMR is considered as a valid alternative for echocardiography 
when an adequate echocardiographic assessment cannot be obtained. It is the diagnostic 
modality of choice for assessing small changes in LA or LV volumes and in LV mass 
(Rademakers, 2003). Clinical use of CMR is expanding and starting to address diastolic LV 
dysfunction. It is not of course practical to obtain CMR in the fresh postoperative cardiac 
surgical patient suspected to have DHF.  
6. Diagnosis of DHF in postoperative heart 
In an ICU environment, the diagnostic criteria are usually based on invasive hemodynamic 
measurements. As ventricular compliance begins to decrease, the end-diastolic pressure 
(EDP) rises but the end-diastolic volume (EDV) remains unchanged. The increase in EDP 
reduces the pressure gradient necessary for ventricular filling and this eventually leads to a 
lower EDV resulting in a decrease in cardiac output via the Frank-Starling mechanism. The 
usual method of assessing cardiac failure by the relationship between ventricular filling 
pressure and stroke volume does not distinguish between systolic and DHF. The end-
diastolic pressure (EDP) is elevated in both types of heart failure. The end-diastolic volume 
(EDV) is increased in systolic heart failure and is decreased in DHF thus it is the parameter 
that will distinguish systolic from DHF (Aurigemma & Gaasch, 2004). The measurement 
that is most often utilized to distinguish between diastolic and systolic heart failure is the 
EF. The EF is normal or near normal in patients with DHF and is reduced in systolic heart 
failure. 
Pulmonary artery catheter with a fast response thermistor can measure the EF of the right 
ventricle. These catheters are able to register the temperature (T) changes during each 
cardiac cycle. The change in temperature is due to dilution of the indicator fluid by venous 
blood that fills the ventricle during diastole. The amount of blood that fills the ventricle 
during diastole is equal to the stroke volume, the temperature differences between each 
plateau on the curve (T1 – T2) is the thermal equivalent of the stroke volume (SV) (Figure 4). 
Temperature T1 is the thermal marker for end-diastolic volume (EDV). The EF becomes 
equivalent to the ratio T1 – T2 / T1 or [SV/EDV] (Spinale etal, 1990,1991). Once the EF is 
measured the stroke volume can be calculated by dividing the cardiac output by heart rate. 
The EDV can be determined by rearranging the EF formula EDV = SV/ EF. The normal RV 
Right ventricular (RV) EF using thermodilution method is 0.45 to 0.50 which is about 10% 
lower than the EF measured by radionuclide imaging (Kay etal, 1983). The accepted normal 
for RVEDV is [80 to 140ml/m2] (Siniscalchi etal, 2005). 
The chief points to help in the diagnosis of DHF in the postoperative heart are: (1) 
Hemodynamic evidence of heart failure (2) Mean pulmonary capillary wedge pressure >12 
mmHg (Paulus etal, 2007) (3) Echocardiographic evidence of raised left atrial pressure (LAP) 
as evidenced by a distended LA with the interatrial septum displaying a fixed curvature 
towards the right atrium (Kusumoto etal 1993; Royse etal, 2004). (4) Echocardiographic 
evidence of a small LV in the absence of hypovolemia and valvular heart disease (5) Low 
EDV as determined by the pulmonary artery catheter (6) EF better or similar to the 
preoperative one. Table 2.  
www.intechopen.com
Coronary Artery Disease 
 – Current Concepts in Epidemiology, Pathophysiology, Diagnostics and Treatment 
 
240 
 Increased PACWP 
 EF  Preop a 
 Evidence of raised LAP a 
 Small LV a 
 Low EDV b 
 Absence of significant pericardial effusion a 
a Revealed by echocardiography. b As determined by pulmonary artery catheter.
Table 2. Features that would suggest DHF in a postoperative heart.PACWP: pulmonary 
artery capillary wedge pressure; CI: cardiac index; LAP: left atrial pressure; EF:; EDV: end 
diastolic volume. Adapted with permission from Elsevier Publishing (Alsaddique, 2008) 
Indeed according to the European criteria, a normal cardiac index in the face of pulmonary 
edema suggests DHF (Paulus et al, 2007). Echocardiography is a useful tool to diagnose 
DHF. In the postoperative heart suspected to have DHF it is not always possible to get an 
adequate assessment. In addition, air trapped within the postoperative mediastinum creates 
poor acoustic windows through which ultrasounds waves cannot pass. An echocardiography 
study that would simply establish that the left ventricular function has not deteriorated 
compared to the preoperative one and rules out the presence of cardiac tamponade or 
significant pericardial effusion can usually be done and would probably suffice under the 
circumstances. If the hemodynamics allow, one can probably use TEE to diagnose of DHF, it 
remains however an invasive procedure that should only be carried out by an experienced 
operator. Published guidelines for performance of TEE should be followed (Nihoyannopoulos 
et al, 2007; Cheiltin et al, 2003; Benjamin et al, 1998). The information gained by TEE should 
be integrated with the rest of the hemodynamic parameters (pulmonary artery occlusion 
pressures or pulmonary artery end-diastolic pressures), LA dimensions, and conventional 
Doppler imaging of mitral inflow in conjunction with TDI of the lateral mitral annular wall.  
 
Fig. 4. Thermodilution EF for the right ventricle. T B baseline blood temperature. T 1, T 2 and 
T 3 are successive temperature plateaux. (Adapted with permission from Elsevier) 
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As it has been determined that objective measurement of LV diastolic function serves to 
confirm rather than establish the diagnosis of DHF. The diagnosis of DHF can be assumed 
without the measurement of the various parameters that reflect LV diastolic function in the 
presence of acute pulmonary edema associated with indirect signs of elevated left atrial 
pressure (Zile eta, 2001). 
7. Perioperative management of DHF 
Management begins by anticipating the problem before it actually happens. In the 
preoperative period, it is important to identify patients who may have or are at risk of DHF. 
Any prior history of DHF is important to identify and attention should be paid to patients 
who are likely to develop it in order to prevent any further deterioration of diastolic 
function in the post operative period. Chronically uncontrolled hypertension is a common 
cause of DHF it should be sought and aggressively treated prior to surgery to reduce the 
risk of perioperative heart failure (Kostis etal, 1997). Hypertension leads to DHF because of 
LV hypertrophy and decreased arterial compliance (Mottram etal, 2005). Diabetes mellitus, 
especially with poor glycemic control, is independently associated with abnormal LV 
relaxation, is similar in severity to that associated with systemic hypertension. The 
combination of diabetes and hypertension is associated with greater abnormality than 
patients with either condition alone. Aggressive control of diabetes, as well as of 
hypertension, should be considered an important component of the management in the pre 
operative period. Tight glycemic control decreases the risk of heart failure in patients with 
diabetes (Iribarren etal, 2001; Liu etal, 2001) , It is helpful to avoid hypovolemia, tachycardia 
and tachyarrhythmias as they impair LV filling by shortening the diastolic phase of the 
cardiac cycle resulting in suboptimal LV filling (Zile & Brutsaert, 2002) . Any reversible 
predisposing factors is to be corrected prior to surgery. Echocardiography is helpful in the 
preoperative assessment of patients especially those with compromised cardiac performance 
in order to identify the nature of heart failure. Risk factors for DHF include elderly patients, 
the female gender, hypertension, increased left ventricular mass, diabetes, obesity, and 
ischemic heart disease (Klapholz etal, 2004)  
8. Intraoperative and postoperative management  
The key to managing DHF is to maintain preoperative parameters as closely as possible. 
Managing DHF is analogous to walking on a tightrope. Any minor deviation from the 
“normal parameters tightrope” could lead to hypotension and low cardiac output, or 
pulmonary venous congestion. The second key principle is to maintain operating volume. 
As shown in Figure 1, the left ventricle with DHF operates at “just adequate” volume. If the 
volume is reduced, then a marked reduction in stroke volume will occur leading to low 
cardiac output and hypotension. It is also important to realize that it is difficult to achieve 
normal volume in DHF because of the relaxation abnormality. Although the left ventricular 
volume appears low, it is in the setting of an elevated left atrial pressure. Management of 
DHF is therefore a process of maintaining a delicate balance and avoiding the contributing 
and triggering factors that can lead to poor hemodynamic outcome. A summary of these 
contributing factors is shown in Figure 5. Reduced LV volume (such as blood loss or 
vasodilation) rapidly leads to hypotension. Tachycardia shortens the diastolic filling time, 
thereby reducing left ventricular volume and stroke volume (Zile & Brutsaert, 2002). High-
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dose inotropes initially may increase blood pressure, but as tachycardia ensues, it would 
cause progressive reduction in left ventricular volume producing a hyperdynamic empty 
ventricle. High levels of positive end expiratory pressure (PEEP), obesity, pericardial or 
pleural effusions cause extrinsic compression of the heart and worsen diastolic function. 
Conversely, excessive administration of fluid in an attempt to improve cardiac output may 
not produce an increase in stroke volume but will produce an increase in end-diastolic 
pressure. This may exacerbate pulmonary venous congestion. Excessive hypertension or 
vasoconstriction will reduce EF and increase left ventricular end-diastolic volume. This has 
the effect of shifting up the end-diastolic pressure-volume curve where a small increase in 
volume will produce a large increase in end-diastolic pressure, increasing the risk of 
pulmonary edema. Bradycardia increases diastolic filling time, and will lead to an increase 
in the peak LVEDP. DHF can lead to pulmonary hypertension due to elevated pressure 
transmitted back through the pulmonary veins (Owan etal, 2006). Hypercapnea and hypoxia 
are potent causes of pulmonary hypertension in the perioperative setting. 
 
Fig. 5. Contributing factors to hemodynamic instability in patients with DHF. Deviation 
from normal parameters can lead to either hypotension/reduced cardiac output, or to 
pulmonary edema. (Adapted with permission from Elsevier) 
9. Management strategies 
A summary of clinical strategies is shown in Figure 6. The mainstay of treatment is to be 
realistic about hemodynamic goals, and to return the patient to normal preoperative 
parameters. Potential reversible causes (particularly extrinsic causes) should be identified and 
managed like pericardial tamponade and significant pericardial effusion as they cause 
resistance to LV filling leading to acute DHF. These conditions should therefore be suspected 
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in the event of unexplained DHF in the postoperative patient. Echocardiography is the most 
effective clinical tool to diagnose and monitor DHF. It can even gives indications about the 
hemodynamic profile of the patient, a raised left atrial pressure can be identified by enlarged 
atria, and a fixed curvature of the interatrial septum bowing from left to right (Royse et al 
2001). One has to assess the different hemodynamic parameters of the patient to find out the 
cause for the imbalance that led to failure. For example, in the setting of reduced volume, 
administration of fluids, avoidance of tachycardia and reducing high dose inotropes will 
improve left ventricular end-diastolic volume. Vasoconstrictors may be required to counteract 
the effect of vasodilation which is seen during and immediately after cardiac surgery, thereby 
returning systemic vascular resistance to normal. Mechanical ventilation may affect 
hemodynamic performance in DHF. The mechanism is complex involving changes in preload 
and afterload for both right and left ventricles. Positive pressure ventilation may reduce 
venous return thereby reducing preload; and it also may reduce afterload enhancing 
ventricular ejection. This may have a variable effect on cardiac output. If the patient is 
normovolemic and intrathoracic pressure is normal, then the effect on afterload reduction may 
increase cardiac output. The beneficial effects of positive pressure ventilation on cardiac 
output are reversed by hypovolemia leading to decreased cardiac output and hypotension. 
Mechanical ventilation is beneficial in order to avoid hypercapnea, and PEEP can help reduce 
pulmonary venous congestion (Pinsky 2005, 2007). The use of continuous positive airway 
pressure (CPAP) by a face mask in the spontaneously breathing patient is reported to be 
effective in the treatment of diastolic dysfunction and may therefore be a useful ventilatory 
support under these circumstances (Benjelid etal, 2005; Moritz etal, 2003; Bersten etal, 1991)  
 
Fig. 6. Strategies to treat DHF in the perioperative setting. Treatment strategies are aimed to 
return to preoperative parameters. RV is right ventricle, PEEP is positive end-expiratory 
pressure; CPAP is continuous positive airway pressure. (Adapted with permission from 
Elsevier) 
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10. The contributing factors 
Acute renal failure leads to volume overload and can trigger DHF (Tsuyuki etal 2001) 
Excessive fluid administration has the same effect and can be a contributing factor for post 
operative DHF. Atrial fibrillation (AF) leads to loss of effective atrial contraction, changes LV 
filling pattern and results in a slowing of myocardial relaxation thereby triggering DHF. 
Pharmacological or electrical cardioversion may be necessary to restore sinus rhythm or at 
least rate control. In the postoperative coronary artery bypass patient unexplained DHF 
should lead to the suspicion of acute graft malfunction, which could happen in the absence of 
any signs of ischemia. Postoperative myocardial ischemia is an important reversible cause of 
diastolic dysfunction in the postoperative period as ischemia significantly slows active 
myocardial relaxation during early diastole affecting thereby LV filling. Ischemia could also 
lead to rhythm disturbances that will further aggravate LV diastolic dysfunction. It is well 
known that tachycardia and dysrhythmias shorten diastole leading to impaired left ventricular 
filling. Restoration of sinus rhythm should always be a priority in management (Zile & 
Brutstaert, (Piaarcchio 2002). If pacing is required, then atrio-ventricular sequential pacing will 
enhance ventricular filling. Ventricular pacing alone leads to loss of the atrial contribution 
(Alsaddique, 2008) and right ventricular pacing may induce dyssynchronous contraction. Pain 
may induce tachycardia and hypertension with the potential of triggering DHF through these 
mechanisms.Sepsis can exacerbate DHF, as it affects both systolic and diastolic function of the 
heart. In case of DHF developing late in the postoperative period sepsis should be considered 
as one of the possibilities. The role of sepsis in causing diastolic failure was identified by using 
pressure-volume loops in anesthetized endotoxemic rabbits. Left ventricular diastolic 
properties were shown to be altered; with prolonged relaxation, decreased compliance leading 
to increased end-diastolic pressure. Diastolic dysfunction can contribute to the development of 
cardiogenic septic shock (Pirracchio etal, 2007). Other factors that can contribute to DHF 
include a large pleural effusion or any other process that causes extrinsic compression of the 
heart or that could potentially impair or delay ventricular filling could contribute to or trigger 
DHF. This includes pericardial tamponade which is in effect “acute extrinsic DHF”. 
11. Additional management considerations 
The incidence of pure DHF in the postoperative heart in not known. Many cases of failure 
that are thought of as systolic failure are in reality diastolic in nature. There is no consensus 
on management of diastolic failure in the postoperative heart or intensive care environment 
in general. Echocardiography can be used not only to diagnose but also to monitor therapy 
and the hemodynamic changes. These points deserve emphasis: 
1. The management of DHF is based on the strategy of avoiding pulmonary congestion 
whilst maintaining adequate cardiac output, and correction of any predisposing factors. 
As the systolic function is maintained in diastolic failure positive inotropes have little role 
in the management. The exception is where there is “low normal” EF or evidence of RV 
dysfunction or RV strain in the setting of pulmonary hypertension. In these situations, 
low dose inotrope therapy may improve cardiac output and hemodynamic stability. High 
dose inotrope therapy will induce tachycardia, and shorten diastolic filling time, leading 
to progressive reduction in LV preload and deterioration in hemodynamics. 
2. In diastolic failure ventricular filling is impaired, diuretic therapy leads to volume 
depletion that will further impair ventricular filling resulting in a more reduction of the 
cardiac output. 
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3. Vasodilation is the enemy of DHF. Though vasodilation facilitates ejection, the heart 
empties but is unable to adequately re-fill, leading to progressive reduction in preload 
and deterioration in hemodynamic conditions. Normalizing systemic vascular 
resistance with a vasoconstrictor helps to maintain hemodynamic stability and 
normotension. 
4. Many patients with DHF also have pulmonary hypertension. Hypotension in this 
setting leads to compromise of RV blood flow and relative RV ischemia, thereby 
causing RV failure. The RV fails by dilating, which leads to further compression of the 
LV and worsening DHF. This can lead to a spiral of progressive hypotension. In these 
circumstances a vasoconstrictor to preserve blood pressure and maintain LV preload, 
and in addition low dose inotrope (such as dobutamine) to support RV function, can 
improve hemodynamic stability. If the situation remains refractory it is worth 
considering nitric oxide (NO) to selectively treat right ventricular pressure overload. 
There is to our knowledge no published work on the use NO in DHF but it remains as 
an option if all else fails (Granton & Moric, 2008; Natori etal, 2003). 
12. Use of diuretics 
Diuretics should be used with caution, as high filling pressure is required to maintain 
cardiac output. Diuresis may result in hypotension in patients with DHF because of the 
steep shape of the left ventricular end-diastolic pressure-volume relationship, where small 
changes in end-diastolic volume will lead to reduced stroke volume. The use of diuretics 
must be countered by increased vigilance of hemodynamic variables, as indiscriminate use 
can be counter-productive (Zile & Burstaert, 2002; Aurigemma & Gaasch 2004).  
13. Antiarrhythmics 
Intravenous digoxin is a commonly used therapy for the management atrial fibrillation and 
paroxysmal atrial tachycardia. Other therapeutic agents include calcium antagonists such as 
verapamil, beta-blockers such as esmololol sotolol for acute rhythm control, or amiodarone. 
The current evidence supports the use of amiodarone for AF occurring after cardiac surgery. 
Amiodarone also reduces perioperative ventricular tachyarrhythmias and strokes, and helps 
reduce duration of hospitalization (Bagshaw etal,2006; Saltman, 2003). Nevertheless digoxin 
continues to be valuable in long-term therapy of atrial flutter and fibrillation. More recently 
digoxin has been the subject of different studies to determine its effects on all forms of heart 
failure (HF). It has been shown that digoxin at serum concentration of 0.5-0.9 ng/mL 
reduces mortality and hospitalizations in all HF patients, including those with DHF. At 
higher serum levels, digoxin reduces HF hospitalization but has no effect on mortality or all-
cause hospitalizations (Ahmed etal, 2006). The recommendation went further to suggest that 
the results of the DIG trial may provide support for the use of digoxin in patients who 
have heart failure with preserved EF, because a trend toward reduction in hospitalizations 
for heart failure was observed with digoxin in the ancillary trial (Ahmed, 2006)]. However 
the guidelines of the American College of Cardiology–American Heart Association Task 
Force for the management of heart failure and the Task Force for the Diagnosis and 
Treatment of Chronic Heart Failure of the European Society of Cardiology do not 
recommend the use of digoxin in patients who have heart failure with preserved EF (Hunt 
etal 2005; Swedberg etal, 2005). 
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13.1 Use of inotropes 
Agressive use of positive inotropic agents have little role in the management of DHF, though 
low dose inotropes may improve stability in the setting of low-normal EF or where there is 
pulmonary hypertension as described earlier [such as a combination of 3-5mcg/kg/min 
dobutamine and norepinepherine 3-5 mcg/min] (Little & Brucks, 2005; Wu & Yu, 2005). This is 
a very common pattern in DHF in the perioperative setting and may be exaccerbated by poor 
cardioprotection (especially to the right heart), myocardial edema or reperfusion injury. 
Pharmacologically, the use of high dose inotropes leads to an increase in heart rate, which 
causes shortening of diastolic filling time leading to reduced ventricular volume and a gradual 
worsening of cardiac output. Therefore, in DHF it is probably wise to accept less than ideal 
hemodynamics provided adequate perfusion is maintained. It is therefore suggested that a 
cardiac index between 1.8 and 2.2 L.min.m-2 is acceptable. Aiming for higher levels of cardiac 
index may not be readily achieved, and the strategy used would necessitate higher doses of 
inotropes and volume, with potential for greater pulmonary venous congestion. The danger of 
increasing inotrope use is that if the patient deteriorates, the typical response is to increase the 
inotropic dose leading to further tachycardia and shortened diastolic filling, thereby further 
reducing stroke volume and worsening cardiac performance, effectively creating a vicious 
circle of deterioration. The art of managing these patients is to achieve the delicate balance 
between hypotension and pulmonary venous congestion by judicious use of vasopressors, 
low-dose inotropes and fluids, such that their baseline hemodynamic state is maintained until 
the recovery processes following surgery abate. 
13.2 Role of Vasodilators 
 It is important to appreciate that vasodilators facilitate ventricular ejection, and in the 
setting of a stiff left ventricle, makes it difficult to re-fill. This is especially important if there 
is associated tachycardia , as this will further exacerbate the inability to adequately refill the 
ventricle. If vasodilators are used they could make the ventricle operates at a lower end-
diastolic volume further contributing to the low cardiac output. Under these circumstances a 
vasoconstrictor may actually be helpful by reducing EF and increasing the end diastolic 
volume. Vasodilators (especially inodilators) are appropriate for secondary DHF (systolic 
and diastolic failure). It is important to remember, however, the goal of maintaining 
preoperative hemodynamics, which means that the level of vasodilation should not depart 
considerably from baseline. In practice, most patients will have a vasodilation state after 
surgery, and are already excessively dilated. Vasodilator use in this setting can be 
counterproductive. If using inodilators, then add norepinepherine to control excessive 
vasodilation, and return it towards normal. 
13.3 Role of vasoconstrictors: 
Vasoconstrictors should be considered as part of the management of DHF, if vasodilation is 
manifest in the postoperative course. Vasodilation is common both during and immediately 
after cardiac surgery, and is part of the sterile inflammatory response syndrome seen 
following cardiac surgery. Diastolic abnormality prevents adequate filling of the left ventricle 
so that the end-diastolic volume progressively declines. Low-dose vasoconstrictors are 
protective in this setting with the aim of normalizing but not increasing vascular resistance.  
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13.4 Other pharmacological agents.  
The value of beta-blockers in the perioperative period has recently been questioned because 
of the POISE trial that has examined their effect on non-cardiac surgery patients (POISE 
study group, 2008). Nevertheless one could extrapolate that the same would probably 
happen in a cohort of cardiac surgery patients. Beta blockers offer cardiac protection in the 
shape of a reduction of myocardial infarction (Andersen etal, 2008; Everly etal, 2004). 
Conversely, the incidence of stroke and its resulting patient disability was increased in the 
treatment group leading to increased mortality (Sear etal, 2008). Caution should be exercised 
with aggressive use of perioperative beta blockade. Beta blockers in the postoperative heart 
are used for control of tachycardia in the presence of adequate volume. An ultra short acting 
agent given intravenously (e.g. esmolol or landiolol that have a very short half life can be 
helpful (Mitchell etal, 2002; Kirshenbaum etal 1985; Yoshida etal, 2008). They can also help 
in case of fast atrial fibrillation to achieve an initial rate control in the process of stabilizing 
the hemodynamics (Kobayashi etal, 2004). Verapamil, a calcium channel blocker, can also be 
used intravenously to control heart rate and to treat fast atrial fibrillation (Abernethy & 
Schwartz, 1999). Calcium channel blockers in general are effective in DHF caused by 
idiopathic hypertrophic cardiomyopathies (Setaro etal 1990), but they do not offer the same 
benefits to diastolic failure caused by other factors (Nishimura etal, 1993). There are no 
drugs specifically marketed for the treatment of diastolic dysfunction. Inodilators may 
improve diastolic function in systolic and DHF, or bi-ventricular failure, as they will 
maintain stroke volume at a lower left ventricular end-diastolic volume. This has the effect 
of the heart working at a lower end-diastolic pressure. Unloading of the right ventricle will 
reduce the effect of left ventricular compression via the interventricular septum.  
Long-term (outpatient) treatment that addresses myocardial remodeling includes ACE-
inhibitors and angiotensin receptor blockers, calcium channel blockers, careful use of 
diuretics such as spironolactone, carvidelol, control of hypertension and treatment of 
myocardial ischemia (Yip etal, 2008; Yamamoto etal, 2005;Bergstrom etal, 2004; Yoshhida 
etal, 2004) Future strategies are likely to address disorders of calcium handling, as well as 
modulating myocardial proteins and collagen subtypes (Kass etal, 2004)  
13.5 Cardiac resynchronization therapy  
Cardiac-resynchronization therapy (CRT) has been shown to improve the rate of survival, 
quality of life, exercise capacity, and functional status in patients with a prolonged QRS 
interval and moderate-to-severe heart failure that is resistant to optimal medical therapy. 
CRT is thought to improve the left ventricular EF and functional status by minimizing 
regional left ventricular delay caused by prolonged ventricular conduction, reducing mitral 
regurgitation and left ventricular reverse remodeling, and normalizing neurohormonal 
factors. Current guidelines support the use of CRT in patients with an EF of 35% or less, 
moderate or severe heart failure (New York Heart Association [NYHA] class III or IV), and a 
prolonged QRS interval [ 120 msec] (Abraham etal, 2002; (Leclercq etal, 2002). CRT did not 
improve peak oxygen consumption in patients with moderate-to-severe heart failure with 
narrow QRS intervals providing evidence these patients may not benefit from this form of 
therapy (Beshai etal, 2007). The effects on diastolic function have been the subject of recent 
studies by load-dependent pulsed-wave Doppler transmitral indices. A number of studies 
have shown that in heart failure patients receiving CRT, improvement in LV diastolic 
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function is coupled to the improvement in LV systolic function (Waggoner etal, 2005). The 
specific value of CRT for the treatment of the DHF as distinct from systolic and diastolic 
failure has not however, been extensively investigated. 
14. Summary  
5. DHF is “ a small stiff heart” with high left atrial pressure, whereas systolic and diastolic 
failure is a dilated heart with reduced EF and a high left atrial pressure, and 
echocardiography is the best way to differentiate these two conditions. 
6. The key operating principle in DHF is to maintain their preoperative haemodynamic 
state and maintain operating volume 
7. The key operating principle of systolic and diastolic failure is to improve stroke volume 
at a lower operating volume 
8. The cardiac index in DHF is not great - but is enough. Do not “shoot for the stars”. 
9. Low dose inotropes and enough vasoconstrictors to normalise vascular resistance can 
improve hemodynamic stability 
10. High dose inotropes are often counterproductive 
11. Excessive vasodilation is the enemy of DHF. 
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globally each year. Such numbers are often difficult to comprehend. Heart disease kills one person every 34
seconds in the USA alone. Although the leading killer, the incidence of cardiovascular disease has declined in
recent years due to a better understanding of the pathology, implementation of lipid lowering therapy new drug
regimens including low molecular weight heparin and antiplatelet drugs such as glycoprotein IIb/IIIa receptor
inhibitors and acute surgical intervention. The disease burden has a great financial impact on global
healthcare systems and major economic consequences for world economies. This text aims to deliver the
current understanding of coronary artery disease and is split into three main sections: 1. Epidemiology and
pathophysiology of coronary artery disease 2. Coronary artery disease diagnostics and 3. Treatment regimens
for coronary artery disease
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